Y-Intercept (HK)’s Kyntra Bio KYNB Stock Holding History

Y-Intercept (HK)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,179	Closed	-$294K	–	1482
2024 Q2	$294K	Buy	+13,179	New	+$407K	0.02%	1038
2023 Q4	–	Sell	-2,283	Closed	-$49.3K	–	1367
2023 Q3	$49.3K	Buy	+2,283	New	+$89.7K	﹤0.01%	997

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Y-Intercept (HK)'s KYNB Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 13,179 shares — an estimated $294K sold.

Y-Intercept (HK) first reported a position in KYNB in Q3 2023 and held it in 2 quarters. The position peaked at $294K in Q2 2024. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

Y-Intercept (HK) reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
Y-Intercept (HK) sold 13,179 Kyntra Bio shares in Q3 2024, an estimated $294K.
Y-Intercept (HK) first reported a position in Kyntra Bio in Q3 2023 and held it in 2 quarters.
Y-Intercept (HK)'s Kyntra Bio position peaked at $294K in Q2 2024.
70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.